Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hypercalcemia Condition: Initial dose |
Dose: Parenteral – 4 IU/kg Frequency: every 12 hours Note: Subcutaneous or Intramuscular |
|
Indication: Hypercalcemia Condition: Maintenance dose |
Dose: Parenteral – 8 IU/kg Frequency: every 12 hours Note: Subcutaneous or Intramuscular; may increase up to a maximum 8 IU/kg every 6 hours if unresponsive |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Dose: Note: Safety and efficacy not established |
Administration
- Give as prescribed
- Store in refrigerator
Side Effect
- Rhinitis (12%)
- Arthralgia (4%)
- Back pain (5%)
- Expistaxis (4%)
- Injection site reactions (10%)
- Nausea (10%)
- Headache (3%)
- Flushing of face or hands (2-5%)
- Abdominal pain
- Possible allergic reactions
- Appetite decreased
- Edema of feet
- Eye pain
- Feverish sensation
- Nausea
- Nocturia
- Possible local irritative effects in the respiratory tract
- Salty taste
- Tremors
- Anaphylactic shock
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Cardiac glycosides, Ca-channel blockers
|
Requires dosage adjustments of these drugs
|
|
Lithium
|
May decrease serum concentration of lithium
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 2-8° C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.